(Q35675602)

English

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy

scientific article published on 6 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

multiple sclerosis

0 references

progressive multifocal leukoencephalopathy

0 references

immune reconstitution inflammatory syndrome

1 reference

based on heuristic

inferred from title

4

object named as

Tania Kümpfel

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Mohammad Ali Sahraian

object named as

Mohammad Ali Sahraian

8

0 references

object named as

Heinz Wiendl

5

0 references

Ernst-Wilhelm Radue

2

object named as

Ernst-Wilhelm Radue

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Imke Metz

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Agustin Oterino

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sven Schippling

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Jens Kuhle

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Francoise Gray

9

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Veronika Jakl

10

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Darius Häusler

11

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Wolfgang Brück

12

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

publication date

6 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Acta Neuropathologica

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

123

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

235-245

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Immune reconstitution inflammatory syndrome in natalizumab-associated PML.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Progressive multifocal leukoencephalopathy and newer biological agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Imaging manifestations of progressive multifocal leukoencephalopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Natalizumab: targeting alpha4-integrins in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Atypical progressive multifocal leukoencephalopathy with plasma-cell infiltrates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

12 July 2018

Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0900-5

21 January 2018

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0900-5

21 January 2018

Reemergence of PML in natalizumab-treated patients--new cases, same concerns

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0900-5

21 January 2018

Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0900-5

21 January 2018

JC virus early protein detection by immunohistochemistry in progressive multifocal leukoencephalopathy: a comparative study with in situ hybridization and polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0900-5

21 January 2018

Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0900-5

21 January 2018

Treatment of progressive multifocal leukoencephalopathy associated with natalizumab

1 reference

https://api.crossref.org/works/10.1007%2FS00401-011-0900-5

21 January 2018

Immunological and clinical consequences of treating a patient with natalizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3259335

25 September 2018

Immune reconstitution inflammatory syndrome after withdrawal of natalizumab?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22057786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00401-011-0900-5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35675602&oldid=2197607640"